Randomized Comparative Clinical Study to Evaluate the Efficacy and Safety of Hijama Bi’l Shart on the Sites of Mankib and Kahil in the Management of Cervical Spondylotic Radiculopathy
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- To evaluate the efficacy and safety of Hijamah bil-Shart on the sites Mankib and Kahil in the treatment of cervical spodylotic radiculopathy.
研究概览
简要总结
Cervical spondylotic radiculopathy (CSR) is a clinical syndrome caused by cervical disc degeneration, hyperostosis, loosening of cervical joint and ligament, and stimulation or compression of cervical nerve roots.Owing to recent lifestyle changes, life and work stress the incidence of cervical spondylosis tends to increase year by year and it is now frequently detected in younger patients however, most patients are usually asymptomatic.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
入排标准
- 年龄范围
- 30.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Patients of cervical spondylosis in the age-group of 30-60 years.
- •2.Patients of all genders 3.Patients with signs and symptoms of cervical spondylosis with radiculopathy and radiological evidences of cervical spondylosis in C3 TO C7 4.Cervical radiculopathy diagnosed by positive response to at least one of the four Upper Limb 5.Tension Tests with symptoms of cervical radiculopathy for less than 6 months 6.Pain intensity score of 30-60 mm on a 100-mm visual analog scale 7.Willingness to give informed consent.
排除标准
- •1.Pregnant and lactating women.
- •2.Any history of cardiac, hepatic, renal insufficiency.
- •3.History of spinal whiplash injury OR fracture.
- •4.History of any spinal surgery.
- •5.Patients taking NSAIDs or corticosteroids (washout period NSAIDs 01 week Corticosteroids 6 weeks).
- •6.Known cases of any other disease of cervical spine like Ankylosing spondylitis, any Vascular lesions and Neoplasms.
- •7.Patients taking any non-pharmacological therapy for the same complaint in the past 4 weeks.
- •Acupuncture, Hijama, physiotherapy).
- •8.Patients of bleeding disorders/ anaemia (Hb lower than 9 gm ).
- •Patients taking Anti-coagulants.
- •9.HIV/AIDS, HCV and HBsAg positive patients.
- •10.Patients with uncontrolled Diabetes mellitus (HbA1C more than 7 percent) and hypertension (Systolic more 129 mm Hg, Diastolic more than 89 mm Hg).
- •11.Alcoholic patients, tobacco users.
结局指标
主要结局
To evaluate the efficacy and safety of Hijamah bil-Shart on the sites Mankib and Kahil in the treatment of cervical spodylotic radiculopathy.
时间窗: First evaluation on 0 day and the last will be on 70th day
To compare the effect of Hijamah bil Shart on the site Mankib with Hijamah bil Shart on Kahil in cervical radiculopathy.
时间窗: First evaluation on 0 day and the last will be on 70th day
次要结局
- To assess the effect of Hijamah bil Shart on quality of life in patients of cervical spondylotic radiculopathy.
研究者
Yasmeen Shamsi
Jamia Hamdard University